Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2026-02-20 @ 12:33 PM
Study NCT ID:
NCT01954251
Status:
COMPLETED
Last Update Posted:
2018-05-02
First Post:
2013-09-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-03
Start Date Type:
None
Primary Completion Date:
2014-06-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-03-20
Completion Date Type:
ACTUAL
First Submit Date:
2013-09-19
First Submit QC Date:
None
Study First Post Date:
2013-10-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-07-31
Results First Submit QC Date:
None
Results First Post Date:
2016-02-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-07-20
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-03-30
Last Update Post Date:
2018-05-02
Last Update Post Date Type:
ACTUAL